Internet Explorer Alert

It appears you are using Internet Explorer as your web browser. Please note, Internet Explorer is no longer up-to-date and can cause problems in how this website functions
This site functions best using the latest versions of any of the following browsers: Edge, Firefox, Chrome, Opera, or Safari.
You can find the latest versions of these browsers at

Advertisement Disclaimer

In this episode Lewis First, MD, MS, FAAP, editor-in-chief of Pediatrics, is back for another edition of “First Up.” He joins hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, with a bird’s-eye view of what’s in the May issue of the journal. The hosts also talk to David Kimberlin, MD, FAAP, editor of the Red Book about what to expect in the 2021 edition released this month.



Subscribe Now


Follow Pediatrics On Call



Lewis First, MD, MS, FAAP


Dr. First is Professor and Chair of the Department of Pediatrics at the University of Vermont (UVM) Larner College of Medicine, Chief of Pediatrics at the UVM Children’s Hospital, and editor-in-chief of the AAP’s peer-reviewed journal Pediatrics. Dr. First also educates the public weekly as a broadcaster and columnist with his “First with Kids” segments that appear on radio, television, and in local newspapers.

David Kimberlin, MD, FAAP


Dr. David Kimberlin holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases at the University of Alabama at Birmingham, where he is Vice Chair for Clinical and Translational Research and Co-Director of the Division of Pediatric Infectious Diseases. Dr. Kimberlin is Editor of the 2021 American Academy of Pediatrics (AAP) Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2018 and 2015 editions, and Associate Editor for the 2009 and 2012 editions. Since 2007, Dr. Kimberlin has served as the AAP Red Book liaison to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Through both the ACIP and the AAP Committee on Infectious Diseases, Dr. Kimberlin has been involved throughout 2020 in major decisions nationally on allocation of the COVID-19 vaccines as they become available. This includes the assessment of the safety and efficacy of the vaccines in populations studied to date, and the development of the phased rollout of the vaccine to the American public to reduce transmission, morbidity, mortality of COVID-19 disease; to help minimize disruption to society and the economy, including maintaining healthcare capacity; and to ensure equity in vaccine allocation and distribution.


Conflict of Interest Disclosure:

Dr. Kimberlin is the site Principal Investigator on Gilead’s pediatric study of remdesivir; all monies go directly to UAB.

Music Credits:
"Steadfast" by Blue Dot Sessions at
Theme music composed by Matthew Simonson at

*The views expressed in this podcast are those of the guests and not necessarily those of the American Academy of Pediatrics.

Feedback Form